The most recent genomewide association study (GWAS) for schizophrenia described an enrichment of FMRP targets among the genomewide significant hits (Schizophrenia Working Group of the PGC, 2014), and in the largest whole exome sequencing study for schizophrenia, enhanced de novo mutations in mRNA targets of FMRP were found (Fromer et al, 2014). Here, FMR1 is linked to schizophrenia.